Materials. SIINFEKL (SIIN) and SIINFEKL-R9 (SIIN*) were synthesized by Genscript with >98% purity, with or without a FITC label on the N-terminus. Polyinosinic-polycytidylic acid, low molecular weight (polyIC) was purchased from Invivogen. Non-immunostimulatory control oligonucleotide (ODN, TCCTGAGCTTGAAGT) was synthesized with a phosphorothioate backbone by IDT. Label-IT nucleic acid labeling kits (Cy5) were purchased from Mirus Bio LLC. PolyIC was labeled according to the manufacturer's protocol. iPEM capsule synthesis. iPEM capsules were synthesized by coating sacrificial colloidal supports with PEMs consisting of SIIN* and polyIC, followed by removal of the core. To form the sacrificial templates from CaCO3, spherical particles were precipitated by adding equal volumes of 0.33 M CaCl2 (Sigma) into 0.33 M Na2CO3.2H2O (Sigma) while mixing at 800 rpm on a stir plate for 5 min. SIIN* and polyIC were prepared in PBS with 0.5 M NaCl and adjusted to the indicated pH values using 0.1 M NaOH. Wash buffer consisted of pH 8, 0.05 M NaCl in PBS. 300 µL of CaCO3 containing 3.69 mg of particles was initially washed twice with wash buffer by incubating particles for 30 sec, then centrifuging particles for 5 sec using a Quickspin Micro 1207 Microcentrifuge (VWR). This sequence was repeated for the second wash. The templates were then suspended in 300 µL of SIIN* solution (1.0 mg/mL) for 1 min and washed three times as above. The washed particles were then collected and suspended for 1 min in 300 µL of either polyIC (1.0 mg/mL) or ODN (1.0 mg/mL). Particles
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were washed three times as above and the sequence was repeated for up to 3 cycles to form CaCO3 particles coated with (SIIN*/polyIC)3 or (SIIN*/ODN)3. The sacrificial templates were removed by collecting the particles with centrifugation (1 min, 1000 g), followed by resuspension in 300 µL of 0.1 M EDTA at the indicated pH values for 30 min. Particles were then washed twice to remove EDTA and finally resuspended in PBS.
iPEM characterization. iPEM build up on silicon and quartz chips was measured by a LSE stokes ellipsometer (Gaertner Scientific Corporation) and Evolution 60 UV-visible spectrophotometer (Thermo Scientific) to assess iPEM thickness and relative cargo loading, respectively. UV-visible spectrophotometry was used to assess relative cargo loading on quartz chips by measuring absorbance values from 200 nm to 700 nm at 1 nm intervals using a solid state sample holder. Wavelengths of 260 nm and 508 nm indicated loading of nucleic acid and peptide, respectively. At least five regions throughout each chip were measured after every 2 bilayers. A Leica SP5X confocal microscope was used to visualize co-localization of both fluorescently-tagged SIIN* (FITC) and polyIC (Cy5) in iPEM capsules. Loading of antigen and adjuvant on sacrificial cores was assessed by measuring the absorbance of the nucleic acid (260 nm) and peptide (FITC, 495 nm) dipping solutions and wash buffer by UVvisible spectrophotometery. Loading of immune signals in iPEM capsules was assessed by incubating capsules in 300 µL of trypsin (0.05%) at 37°C for 1 hr, then measuring the peptide (FITC; Ex: 495, Em: 520) and polyIC (Cy5; Ex: 650, Em: 670) signals by fluorimetry using a Gemini XPS fluorescence microplate reader (Molecular Devices). Capsule sizes were measured using ImageJ to analyze diameters of at least 50 particles. For stability studies, capsules were incubated in PBS, incomplete media (RPMI), or complete DC media (with 10% FBS; detailed below) at 37 °C and the size was measured at the indicated times.
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In vitro dendritic cell studies. All animal and cell experiments were approved by the institutional animal care and use committee (IACUC) at University of Maryland, College Park.
Splenic dendritic cells (DCs) were isolated from C57BL/6 mice purchased from The Jackson Laboratory (Bar Harbor, ME) with CD11c positive magnetic isolation kit (Miltenyi) following the manufacturer's instructions. Briefly, after euthanizing mice, spleens were harvested and minced by forceps. Minced spleens were incubated with 4 mL of spleen dissociation medium (Stemcell) for 30 min at 37°C followed by homogenizing with a 16 G needle and 3 mL syringe. To the homogenized medium, 80 µL of 0.5 M EDTA was added at a final concentration of 10 mM and incubated for 5 min at room temperature, then passed through a 70 µm cell strainer (BD Biosciences) and centrifuged at 300 g for 10 min at 4°C to acquire splenocytes. Cells were then resuspended with 400 µL of MACS buffer (1% BSA + 2 mM EDTA in PBS) per 10 8 cells and mixed with 100 µL of CD11c microbeads per 10 8 cells and incubated for 15 min at 4°C. After incubation, cells were washed with 49 mL buffer and centrifuged at 200 g for 10 min at 4°C. Washed cells were then re-suspended in 500 µL buffer per 10 8 cells and passed through a pre-wetted LS column (Miltenyi) in a magnet followed by washing three times with 3 mL MACS buffer. After the last wash, the LS column was removed from the magnet and flushed with 5 mL buffer. The flushed cell suspension was then centrifuged at 300 g for 10 min at 4°C to collect pelleted cells. The cell pellet was then resuspended with 1 mL DC medium (RPMI1640, 10% FBS, 0.5% Penicillin Streptomycin, 50 µM 2-mercaptoethanol (2-ME)) prior to use. signaling was measured by absorbance at 625 nm using a spectrophotometer.
In vitro CD8 + T cell expansion. OT-I mice (C57BL/6-Tg(TcraTcrb)1100Mjb/J) were purchased from The Jackson Laboratory (Bar Harbor, ME). [1] Three days after immunization, CD11c-enriched DCs from naïve, soluble vaccine-immunized, and iPEM capsule-immunized C57BL/6 mice were isolated. T cells were isolated from the spleens of OT-I mice using a negative selection CD8 isolation kit (Stemcell). Briefly, splenocytes were resuspended at 1x10 8 cells/mL (up to 8 mL total volume) followed by adding 50 µL of normal rat serum (Stemcell) per 1 mL of cells. After mixing, 50 µL of mouse CD8 + T Cell Isolation Cocktail (Stemcell) per 1 mL of cells was added and incubated at room temperature for 10 min.
Streptavidin RapidSpheres (Stemcell) were then added to the cell suspension at 125 µL/mL of cells and incubated at room temperature for 5 min. After incubation, the cell suspension volume was brought to a total volume of 5 mL (for <4x10 8 cells) with recommended medium (0.5% BSA and 0.2 mM EDTA in PBS). The cell suspension was placed in a 14 mL tube without a cap in the magnet for 2.5 min and carefully the desired CD8 + T cells were poured into a new tube. Resulting cells were washed twice to remove any serum and labeled with 5 µM of proliferation dye eFluor 670 (eBioscience) for 10 min at 37°C in the dark. After 10 min, the dye was neutralized with 5 times volume of T cell medium (RPMI1640, 10% FBS, 1x non-essential amino acid, 10 mM HEPES, 2 mM L-glutamine, 0.5% Penicillin S5 Streptomycin, 50 µM 2-ME) followed by washing three times with T cell medium. Resulting cells (3x10 5 cells/50 µL) were added into wells containing DCs/capsules and incubated for 48 hrs for the T cell co-culture assay. After 48 hrs, the resulting cell population was divided into two portions for proliferation analysis and intracellular cytokine staining (ICCS).
To assess T cell proliferation, cells were blocked with anti-CD16/32 as described previously and stained with anti-CD3e (PE-Cy7) and anti-CD8a (APC) for CD8 + T cells. ELISA assay. All ELISA assays were conducted using mouse IL-1β, IL-6, and IFN-γ
OptEIA reagents according to the manufacturer's instructions (BD Biosciences). Supernatants were collected and analyzed without purification using 4-10x dilutions.
Mechanistic in vivo studies. Six to eight week old C57BL/6 female mice from The Jackson Laboratory were immunized by intradermal injection with capsules, soluble SIIN and polyIC, or left untreated as above. Three days after immunization, DCs from draining lymph nodes and spleens were isolated by positive CD11c selection as described above. Cells were then S7 stained with antibodies against classical DC activation markers and analyzed by flow cytometry, as above. To test if DCs isolated from immunized mice present peptides from iPEM capsules in a manner that can expand antigen-specific CD8 + T cells (OT-I), DCs isolated from iPEM-immunized mice on Day 3 were co-cultured with CD8 + T cell from OT-I mice for 48 hrs. Proliferation and cytokine secretion were then assessed by fluorescence dilution assays and ELISA as described above. For immunohistochemical analysis, lymph nodes were removed on day 3, frozen, sectioned at 10 µm intervals, then the tissue was fixed.
Fixed sections were blocked with 5% donkey serum (Sigma) and 5% goat serum . Fluorescently-labeled antigen (FITC, green) and adjuvant (Cy3, red; Cy5, magenta) can be independently visualized without signal overlap between filter sets. iPEMs were assembled on quartz microscope slides using the indicated components, then a needle was used to remove of portion of the film to provide contrast for imaging (white lines). 
